Clinical trials
Active, not recruiting Phase 1 COVID-19 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Duke University | 1 |
| GC Biopharma Corp | 1 |
| Glycovax Pharma Inc. | 1 |
| Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair | 1 |
| Interna Therapeutics Ltd. | 1 |
| Invivyd, Inc. | 1 |
| LucasBio | 1 |
| Rokote Laboratories Finland Oy | 1 |
| University Hospital Tuebingen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 13 |
| Infections | 2 |
| Coronavirus Infections | 1 |
| Hematologic Neoplasms | 1 |
| Pneumonia | 1 |
| Signs and Symptoms, Respiratory | 1 |
| Virus Diseases | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.